Skip to main content
Premium Trial:

Request an Annual Quote

$14.9M for Microbiome Research in Canada

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Canadian government and health-related organizations and foundations yesterday announced more than C$15 million ($14.9 million) in funding for seven microbiome research projects.

The federal government is contributing more than C$14 million over five years to the effort. Another C$1.4 million is being provided by Genome British Columbia, the Crohn's and Colitis Foundation of Canada, and the Canadian Cystic Fibrosis Foundation.

"The goal of this initiative is to discover which microbial communities exist in different parts of the human body and to explore how these communities impact and influence human health or disease," Marc Ouellette, scientific director for the Canadian Institutes of Health Research, said in a statement.

The seven projects target the vaginal microbiome; Crohn's disease; microbial diversity and function; cystic fibrosis; microbiotic influence on immune development and disease; microbiota in children; and bacterial interplay in the immune system.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.